- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03720730
SmartCriseS - Smartphone Survey of Suicidal Risk (SmartCriseS)
Sleep and Appetite Measures as Suicidal Risk Factors in a French- Spanish Cohort of Suicidal Patients.
Sleep and appetite disorders as well as social exclusion, have been linked to the emergence of suicidal ideation (SI) and suicide attempts.This study aims to evaluate the relationship between those factors and suicidal ideation and behaviour. To assess those factors an ecological momentary assessment (EMA) desing will be used.
EMA will be carried out using 2 applications integrated into the smartphone of participants (Android or iOS), one to make an explicit data collection with questions and another one for the implicit collection of data from mobile sensors.
1044 suicide attempters will be included in three sites and followed for 6 months. Participants will be evaluated at inclusion and at the end of follow-up. The hypothesis is that sleep, appetite and social exclusion factors collected with the smartphone application will be linked to the intensity of death wish, suicidal ideations and suicidal attempts.
An auxiliary study will also be led with 300 patients carrying an actimeter for the 30 first days after inclusion. This will help collecting more accurate data on various sleep parameters.
Study Overview
Status
Intervention / Treatment
Detailed Description
The proposed study will use ecological momentary assessment (EMA) via smartphone applications (apps) and wearable trackers to examine the relationship between suicidality (wish to die, suicidal ideation and suicide attempt) and changes in sleep quality and disturbed appetite. These behavioral markers, if the hypothesis is proven true, could help predict increased suicidal risk in real-time within a vulnerable population across different cultures.
The study aims to: (1) Establish the extent to which quality of sleep is related to suicide ideation and suicide attempts; (2) Establish the extent to which change in appetite is related to suicide ideation and suicide attempts; (3) Determine the emotional impact of the app when suicidality is assessed; (4) Clarify the timeline of the relationship between sleep disturbances and suicidal behavior; (5) Develop personalized algorithms based on EMA protocol and motor activity markers or "signatures" to assess the risk of suicide attempts.
The hypothesis is that variations in sleep quality will correlate with increased wish to die, suicide ideation and suicide attempts. It is expected that a decrease in sleep quality will be a suicide risk marker especially among young individuals.
This prospective cross-national study will use the infrastructure of an existing network (WORECA). Woreca has defined a common protocol of suicide assessment, data sharing and analysis strategy.
1044 suicide attempters will be included and followed for 6 months. Each participant will be assessed using an EMA protocol via two smartphone apps: (1) One app will ask everyday questions following a dynamic protocol to assess quality of sleep, appetite, suicidal ideation and psychopathology; (2) the other app will record activity using smartphone sensors. Additionally, 300 participants (150 in France and 150 in Spain) will have their sleep phases and other physiological changes during sleep monitored with a wearable armband. Study outcomes include wish to live, wish to die, suicidal ideation, and suicide attempt during the follow-up period.
A multi-level logit regression analysis will be used to account for multiple observations per individual, to identify individual-level (sleep, appetite, socio-demographic, clinical data, treatment data) and site-level characteristics associated with death desire, suicidal ideation or suicide attempt (aim 1 and 2). Hazards models will also be used to relate covariate characteristics (sleep, appetite, sociodemographic, clinical data, treatment data) with time to suicide reattempt during the follow-up period (aim 1 and 2). Data mining (machine learning) techniques will be used to examine risk factors, patterns of illness evolution (aim 3 and 4) and patient stratification by level of suicidal risk (aim 5).
Identifying surrogate markers of suicidality related with physiological functions, which carry less or no stigma for the patients and are easier to report, or have a lower reporting threshold is an essential task. These markers would allow to predict in real-time an increase in suicidal risk within a vulnerable population and ultimately help to prevent and even personalize treatment.Suicidal behaviours, including suicidal ideation, are preventable but to be efficient, prevention needs to rely on the identication of specific risk factors.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jorge Lopez Castroman, MD PhD
- Phone Number: +33 4 66 68 34 26
- Email: Jorge.lopezcastroman@chu-nimes.fr
Study Contact Backup
- Name: Enrique Baca-Garcia, MD PhD
- Email: ebaca@fjd.es
Study Locations
-
-
-
Montpellier, France, 34295
- Recruiting
- CHU Montpellier
-
Contact:
- Catherine Genty, MD
- Phone Number: + 33 4 67 99 61 45 75
- Email: c-genty@chu-montpellier.fr
-
-
-
-
-
Madrid, Spain, 28040
- Recruiting
- Fundación Jiménez Díaz Hospital
-
Contact:
- Maria Barrigon, MD PhD
- Phone Number: 00 34 915 41 72 67
- Email: luisa.barrigon@fjd.es
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- To be at least 18 years old
- To use a smartphone as a personal phone
- To have consulted in the context of a suicidal crisis within the last 7 days
- To be able to understand the nature, purpose and methodoly of the study.
- To be in a minimal treatment phase (according to the clinician's judgment).
- To accept participating to the study and the 6 months follow-up and to have signed the informed consent
Exclusion Criteria:
- Refusal of participation
- Subject protected by law (guardianship)
- Deprived of liberty Subject (by judicial or administrative decision)
- Diagnosis of a current hypomanic, manic or mixed episode, or a diagnosis of schizoaffective disorder or schizophrenia.
- No affiliation to the social safety system
- Exclusion period in relation to another protocol
- 65 years old patients and older with an MMSE score < 24 at baseline
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Study participants
Patients with a recent history of suicidal crisis (within the last 7 days) will use a smartphone application to evaluate sleep, appetite and social parameters.
|
The mobile application (EMA) combines an explicit data collection with an implicit one. For the explicit data collection with Memind application, patients will have to answer specific questionnaires about sleep, appetite and social factors. Some of the questions will be asked on regular basis, at the same time everyday, while others will be asked randomly during the day (between 9 a.m and 9 p.m). The implicit data collecting will be carried out using smartphone sensors (application eB2). |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Occurrence of suicidal event assessed by Columbia-Suicide Severity Rating Scale (C-SSRS)
Time Frame: 6 months
|
Evaluate the occurrence of a suicidal event with the C-SSRS.
The questionnaire includes four subscales.
The suicidal ideation severity subscale ranges from 1 to 5 (with higher number indicating more severe ideation).
The intensity of ideation subscale includes 5 questions each one ranging from 1 to 5 (with higher number indicating more intense ideation).
The suicidal behavior subscale includes 4 yes/no questions.
The suicidal behavior lethality subscale inquires about the level of actual or potential medical damage.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of insomnia assessed by ecological momentary assessment (EMA)
Time Frame: 6 months
|
Evaluate insomnia with the Insomnia Severity Index (ISI) score using EMA questions.
The ISI score ranges from 0 to 27 (higher number indicating more severe insomnia).
|
6 months
|
Evaluation of insomnia assessed by Insomnia Severity Index (ISI)
Time Frame: 6 months
|
Evaluate insomnia with the ISI score.
The ISI score ranges from 0 to 27 (higher number indicating more severe insomnia).
|
6 months
|
Evaluation of appetite assessed by ecological momentary assessment (EMA)
Time Frame: 6 months
|
Evaluate appetite using the Council of Nutrition Appetite Questionnaire (CNAQ) score with EMA questions.
The CNAQ score ranges from 8 to 40 (a score of less than 28 is cause for concern, with lower number indicating greater risk).
|
6 months
|
Evaluation of sensibility to social exclusion assessed by ecological momentary assessment (EMA)
Time Frame: 6 months
|
Evaluate social sensibility with EMA questions based on the Perceived Social Support and Interpersonal Needs Questionnaire
|
6 months
|
Evaluation of suicidal ideation intensity assessed by Columbia-Suicide Severity Rating Scale (C-SSRS)
Time Frame: 6 months
|
Evaluate suicidal ideation intensity with the C-SSRS.
The severity of suicidal ideation subscale ranges from 1 to 5 (with higher number indicating more severe ideation).
The intensity of ideation subscale includes 5 questions each ranging from 1 to 5 (with higher number indicating more intense ideation).
The suicidal behavior subscale includes 4 yes/no questions.
The suicidal behavior lethality subscale inquires about the level of actual or potential medical damage.
|
6 months
|
Evaluation of the intensity of death wish assessed by ecological momentary assessment (EMA)
Time Frame: 6 months
|
Evaluate death wish intensity with analogical scales
|
6 months
|
Evaluation of suicide attempts severity assessed by Columbia-Suicide Severity Rating Scale (C-SSRS)
Time Frame: 6 months
|
Evaluate suicide attempts severity with the C-SSRS.
The severity of suicidal ideation subscale ranges from 1 to 5 (with higher number indicating more severe ideation).
The intensity of ideation subscale includes 5 questions each ranging from 1 to 5 (with higher number indicating more intense ideation).
The suicidal behavior subscale includes 4 yes/no questions.
The suicidal behavior lethality subscale inquires about the level of actual or potential medical damage.
|
6 months
|
Evaluation of sleep duration assessed by Pittsburgh Sleep Quality Index (PSQI)
Time Frame: 6 months
|
Evaluate sleep duration with one item from the PSQI (hours of night sleep during the past week) using EMA
|
6 months
|
Evaluation of sleep duration assessed by Pittsburgh Sleep Quality Index (PSQI)
Time Frame: 6 months
|
Evaluate sleep duration with the PSQI at the end of follow-up.
The PSQI score ranges from 0 to 21 (lower score indicating healthier sleep quality)
|
6 months
|
Evaluation of physical activity by eB2
Time Frame: 6 months
|
Evaluate physical activity with smartphone sensors (eB2).
|
6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of sleep quantity with the actimeter
Time Frame: 1 month
|
Evaluate sleep quantity with the actimeter, only for patients included in the auxiliary study
|
1 month
|
Evaluation of sleep quantity with the sleep diary
Time Frame: 1 month
|
Evaluate sleep quantity with the sleep diary (self-report), only for patients included in the auxiliary study
|
1 month
|
Evaluation of sleep quality with the actimeter
Time Frame: 1 month
|
Evaluate sleep quality with the actimeter.
Only for patients included in the auxiliary study.
|
1 month
|
Evaluation of sleep quality with the sleep diary
Time Frame: 1 month
|
Evaluate sleep quality with the sleep diary.
Only for patients included in the auxiliary study
|
1 month
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2.
- Berrouiguet S, Barrigon ML, Castroman JL, Courtet P, Artes-Rodriguez A, Baca-Garcia E. Combining mobile-health (mHealth) and artificial intelligence (AI) methods to avoid suicide attempts: the Smartcrises study protocol. BMC Psychiatry. 2019 Sep 7;19(1):277. doi: 10.1186/s12888-019-2260-y.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UF 9821
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicidal Ideation
-
University of WashingtonUnited States Department of Defense; Military Suicide Research ConsortiumCompletedSuicidal and Self-injurious Behavior | Suicidal Ideation ActiveUnited States
-
The Catholic University of AmericaUniversity of Washington; VA Office of Research and DevelopmentCompletedSuicidal and Self-injurious Behavior | Suicidal Ideation Active
-
Emory UniversityGeorgia Institute of TechnologyCompletedSuicide, Suicidal IdeationUnited States
-
Henry M. Jackson Foundation for the Advancement...University of Pennsylvania; University of Michigan; Duke University; US Department... and other collaboratorsUnknownSuicide, Attempted | Suicidal Ideation ActiveUnited States
-
Technische Universität DresdenUnknownDepression | Suicidal Ideation/BehaviorGermany
-
International Islamic University, IslamabadRecruitingImpulsivity | Suicidal Ideation and BehaviorPakistan
-
VA Office of Research and DevelopmentCentral Texas Veterans Health Care SystemRecruitingHealth | Reintegration Difficulties | Suicidal Ideation and Behaviors | ConnectednessUnited States
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Eisenhower Army Medical CenterAugusta University; The Geneva Foundation; Congressionally Directed Medical Research...CompletedSuicidal Ideation | Suicide | Suicidal Intention | Suicidal Impulses | Suicidal and Self-Injurious Behavior | Suicidal DepressionUnited States
-
Ohio State UniversityUniversity of Minnesota; Rutgers UniversityCompletedSuicidal Ideation | SuicidalUnited States
Clinical Trials on EMA
-
Massachusetts General HospitalBoston UniversityRecruitingSchizophrenia | PsychosisUnited States
-
Northeastern UniversityNational Center for Advancing Translational Sciences (NCATS)Completed
-
Johns Hopkins UniversityNational Institute on Aging (NIA)Completed
-
The University of Hong KongActive, not recruiting
-
Click Therapeutics, Inc.CompletedCovid19 | Stress | Stress, Psychological | LonelinessUnited States
-
Chestnut Health SystemsNational Institute on Drug Abuse (NIDA)CompletedRecovery | Substance Use Disorder (SUD)United States
-
Hôpital le VinatierInstitut National de la Santé Et de la Recherche Médicale, FranceNot yet recruitingGambling Addiction
-
University of OklahomaRecruitingHead and Neck CancerUnited States
-
The University of Hong KongHealth and Medical Research FundActive, not recruitingSmoking CessationHong Kong
-
University of ZurichRadboud University Medical Center; Universitaire Ziekenhuizen KU Leuven; Johannes...Completed